摘要
化疗广泛应用于癌症治疗。然而,它为患者带来了不必要的副作用。为了避免这些不良反应,纳米载体已被开发,其可以装载化学治疗药物,直接到达癌症部位,并且一旦到达,便受到刺激释放药物。脂质体可以被化学修饰来增加其循环时间、稳定性和对特定刺激的敏感性。此外,配体可结合至脂质体表面,特异性结合癌细胞表面上超表达的受体并通过内吞作用实现后续内化。使用一个触发机制,包括温度、超声、酶或PH值改变,药物释放被控制和诱导在细胞内,从而避免了药物在体循环中释放,这相应减少了规化疗的不必要副作用。因其众所周知的物理特性和医学中的前期使用,超声已被作为从脂质体释放药物的触发器被广泛研究。本文综述了使用不同的触发机制(集中于超声)的脂质体药物输送系统。也调查了超声释放的物理机制,总结了体内外研究结果。
关键词: 药物输送系统,脂质体,纳米载体,触发传送,超声。
图形摘要
Current Cancer Drug Targets
Title:Review on Triggered Liposomal Drug Delivery with a Focus on Ultrasound
Volume: 15 Issue: 4
Author(s): Hesham G. Moussa, Ana M. Martins and Ghaleb A. Husseini
Affiliation:
关键词: 药物输送系统,脂质体,纳米载体,触发传送,超声。
摘要: Chemotherapy is widely used for cancer treatment; however, it causes unwanted side effects in patients. To avoid these adverse effects, nanocarriers have been developed, which can be loaded with the chemotherapeutic agents, directed to the cancer site and, once there, are exposed to stimuli that will trigger the drug release.
Liposomes can be chemically modified to increase their circulation time, their stability, and their sensitivity to specific stimulus. Additionally, ligands can be conjugated to their surface, allowing for their specific binding to receptors overexpressed on the surface of cancer cells and the subsequent internalization via endocytosis. Using a triggering mechanism, including temperature, ultrasound, enzymes or a change in pH, the release of the drug is controlled and induced inside the cells, hence avoiding drug release in systemic circulation, which in turn reduces the undesired side effects of conventional chemotherapy. Ultrasound has been widely studied as a drug release trigger from liposomes, due to its well-known physics and previous uses in medicine.
This review focuses on liposome-based drug delivery systems, using different trigger mechanisms, with a focus on ultrasound. The physical mechanisms of ultrasound release are also investigated and the results of in vitro and in vivo studies are summarized.
Export Options
About this article
Cite this article as:
Hesham G. Moussa, Ana M. Martins and Ghaleb A. Husseini , Review on Triggered Liposomal Drug Delivery with a Focus on Ultrasound, Current Cancer Drug Targets 2015; 15 (4) . https://dx.doi.org/10.2174/1568009615666150311100610
DOI https://dx.doi.org/10.2174/1568009615666150311100610 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanobiotechnology and Nanostructured Therapeutic Delivery Systems
Recent Patents on Biomedical Engineering (Discontinued) 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience
Current Radiopharmaceuticals Targeting Inhibition of COX-2: A Review of Patents, 2002 - 2006
Recent Patents on Inflammation & Allergy Drug Discovery Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways
Current Pharmaceutical Design HIV-1 Rev Multimerization: Mechanism and Insights
Current HIV Research Perfusion Computed Tomography and its Application in Oncologic Practice
Current Molecular Imaging (Discontinued) Current View on the Mechanism of Action of Perifosine in Cancer
Anti-Cancer Agents in Medicinal Chemistry Zinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Emergence of the “New” Head and Neck Cancer Prevailing to Young, Nonsmoker, and Nondrinker - Oropharyngeal Cancer Associated with HPV Positive)
Current Cancer Therapy Reviews Sphingolipid Modulation: A Strategy for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Mechanism in Gastric Cancer Chemoprevention by Allicin
Anti-Cancer Agents in Medicinal Chemistry Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer
Recent Patents on Nanotechnology Reducing radiation in chronic total occlusion percutaneous coronary interventions
Current Cardiology Reviews Structure-Activity Relationship of Supramolecular Compounds in Drug Delivery
Mini-Reviews in Organic Chemistry Novel PET Tracers in the Management of Cardiac Sarcoidosis
Current Radiopharmaceuticals Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Current Molecular Medicine Inflammation and Anemia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry DNA Damage-inducing Compounds: Unraveling their Pleiotropic Effects Using High Throughput Sequencing
Current Medicinal Chemistry Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery Radiolabeling Methods and Nuclear Imaging Techniques in the Design of New Polymeric Carriers for Cancer Therapy
Current Applied Polymer Science